miR-223 and miR-142 attenuate hematopoietic cell proliferation, and miR-223 positively regulates miR-142 through LMO2 isoforms and CEBP-β

被引:84
|
作者
Sun, Wei [1 ]
Shen, Wenwen [1 ]
Yang, Shuang [1 ]
Hu, Fen [1 ]
Li, Huihui [1 ]
Zhu, Tian-Hui [1 ]
机构
[1] Nankai Univ, Coll Med, Mol Genet Lab, Tianjin 300071, Peoples R China
基金
中国国家自然科学基金;
关键词
miR-142; miR-223; LMO2-L; LMO2-S; CEBP-beta; proliferation; TRANSCRIPTION FACTORS; GENE-EXPRESSION; NUCLEAR EXPORT; PROTEIN LMO2; C/EBP-ALPHA; MICRORNAS; LEUKEMIA; ONCOGENE; TRANSLOCATIONS; PROMOTER;
D O I
10.1038/cr.2010.134
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
miR-142 and miR-223 have been identified as hematopoietic specific microRNAs. miR-223 has crucial functions in myeloid lineage development. However, the function of miR-142 remains unclear. In this study, we found that both miR-142 and miR-223 attenuated the proliferation of hematopoietic cells, and that miR-223 up-regulated miR-142 expression through the LMO2-L/-S isoforms and CEBP-beta. miR-223 negatively regulated both LMO2-U-S isoforms and CEBP-beta post-transcriptionally, while CEBP-beta positively regulated the LMO2-L/-S isoforms and both of the LMO2-L/-S isoforms negatively regulated miR-142. These results reveal a novel miR-223-CEBP-beta-LMO2-miR-142 regulatory pathway, which has pivotal functions in hematopoiesis.
引用
收藏
页码:1158 / 1169
页数:12
相关论文
共 50 条
  • [1] miR-223 and miR-142 attenuate hematopoietic cell proliferation, and miR-223 positively regulates miR-142 through LMO2 isoforms and CEBP-β
    Wei Sun
    Wenwen Shen
    Shuang Yang
    Fen Hu
    Huihui Li
    Tian-Hui Zhu
    Cell Research, 2010, 20 : 1158 - 1169
  • [2] miR-142 regulates mature B cell migration
    Derudder, E.
    Hagen, M.
    Olson, W.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2022, 52 : 307 - 308
  • [3] A potential role of microvesicle-containing miR-223/142 in lung inflammation
    Zhang, Duo
    Lee, Heedoo
    Wang, Xiaoyun
    Groot, Michael
    Sharma, Lokesh
    Dela Cruz, Charles S.
    Jin, Yang
    THORAX, 2019, 74 (09) : 865 - 874
  • [4] miR-142 controls metabolic reprogramming that regulates dendritic cell activation
    Sun, Yaping
    Oravecz-Wilson, Katherine
    Bridges, Sydney
    McEachin, Richard
    Wu, Julia
    Kim, Stephanie H.
    Taylor, Austin
    Zajac, Cynthia
    Fujiwara, Hideaki
    Peltier, Daniel Christopher
    Saunders, Thomas
    Reddy, Pavan
    JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (05): : 2029 - 2042
  • [5] miR-223 Regulates Adipogenic and Osteogenic Differentiation of Mesenchymal Stem Cells Through a C/EBPs/miR-223/FGFR2 Regulatory Feedback Loop
    Guan, Xiaohui
    Gao, Yifei
    Zhou, Jie
    Wang, Jun
    Zheng, Fang
    Guo, Fei
    Chang, Ailing
    Li, Xiaoxia
    Wang, Baoli
    STEM CELLS, 2015, 33 (05) : 1589 - 1600
  • [6] MiR-223 suppresses proliferation and promotes apoptosis of diffuse large B-cell lymphoma cells through Lmo2 and MAPK signaling pathway
    Zhang, Yongmei
    Zhang, Jie
    JOURNAL OF BUON, 2021, 26 (02): : 580 - 586
  • [7] MiR-142 inhibits lung cancer cell proliferation and promotes apoptosis by targeting XIAP
    Wu, X-B
    Li, Q-H
    Zhang, N.
    Li, M.
    Li, K.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (17) : 7430 - 7437
  • [8] MiR-223 Suppresses Cell Proliferation by Targeting IGF-1R
    Jia, Cheng You
    Li, Hui Hui
    Zhu, Xu Chao
    Dong, Yi Wei
    Fu, Da
    Zhao, Qian Lei
    Wu, Wei
    Wu, Xing Zhong
    PLOS ONE, 2011, 6 (11):
  • [9] Reduced Platelet miR-223 Induction in Kawasaki Disease Leads to Severe Coronary Artery Pathology Through a miR-223/PDGFRβ Vascular Smooth Muscle Cell Axis
    Zhang, Yuan
    Wang, Yanfei
    Zhang, Li
    Xia, Luoxing
    Zheng, Minhui
    Zeng, Zhi
    Liu, Yingying
    Yarovinsky, Timur
    Ostriker, Allison C.
    Fan, Xuejiao
    Weng, Kai
    Su, Meiling
    Huang, Ping
    Martin, Kathleen A.
    Hwa, John
    Tang, Wai Ho
    CIRCULATION RESEARCH, 2020, 127 (07) : 855 - 873
  • [10] miR-223 regulates oral squamous cell carcinoma metastasis through the Wnt/β-catenin signaling pathway
    Wei, Zihao
    Wang, Yun
    Jiang, Lu
    Ji, Ning
    Wang, Ying
    Chen, Fangman
    Li, Taiwen
    Li, Jing
    Xu, Hao
    Zeng, Xin
    Chen, Qianming
    ORAL ONCOLOGY, 2020, 109